Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

FDA awards orphan drug designation to Onconase in malignant mesothelioma

Feb. 1, 2007

Exelixis files IND for XL-418

Feb. 1, 2007

Debiopharm signs agreement with Kirin Brewery for Debio-0719

Feb. 1, 2007

Snapshots: studies of panitumumab treatment for colorectal cancer

Feb. 1, 2007

Snapshots of bevacizumab regimens from the Gastrointestinal Cancers Symposium

Feb. 1, 2007

Recent patents impart new therapeutic agents for cancer

Feb. 1, 2007

Phase II enrollment open for glufosfamide in platinum-resistant ovarian cancer

Jan. 31, 2007

Intravenous administration approved for Vidaza

Jan. 31, 2007

Sunesis to advance phase II SCLC study of SNS-595 into second stage

Jan. 31, 2007

Novel inhibitor of protein-protein interactions in the Wnt pathway suppresses tumor growth in vivo

Jan. 31, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...